Zomedica acquires Assisi Animal Health for $18M cash plus warrants

Zomedica Corp.

Acquired substantially all assets of Assisi Animal Health for $18.0M cash and a 10-year warrant for 22M common shares at $0.252 per share.
Acquisition closed July 15, 2022; deal includes escrow for indemnification ($1.4M) and post-closing adjustments ($200k).
Assisi produces tPEMF devices (Loop, Loop Lounge, DentaLoop, Calmer Canine) that reduce pain and inflammation in companion animals.
Products complement Zomedica's PulseVet shock wave therapy and extend at-home care by pet owners.
Over 100,000 pets treated with Assisi products since 2013; supported by peer-reviewed studies and veterinary opinion leaders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.